PHGDH was expressed in triple-negative breast cancers and squamous cell carcinomas, and TRIM29 was expressed in squamous cell carcinomas of the uterine cervix and urothelial carcinomas, which are findings that are highly compatible with the previous studies mentioned above. Here, PHGDH is linked to triple-negative breast carcinoma.